Nancy A. Grygiel, Senior Vice President & Chief Compliance Officer, on August 06, 2026, sold 2,970 shares in Amgen (AMGN) for $1,194,416. Following the Form 4 filing with the SEC, Grygiel has control over a total of 7,447 common shares of the company, with 7,340 shares held directly and 107 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/xslF345X05/form4.xml